Market Overview

Top 4 Stocks In The Drugs-Generic Industry With The Highest Profit Margin

Related HITK
Hi-Tech Pharmacal Receives FDA Final Approval for Bromfenac Ophthalmic Solution, 0.09%
US Stock Futures Up; Jobless Claims Data In Focus
Related AKRX
5 Drug Companies Profiting From Generics
Acasti Pharma (ACST) Jumps: Stock Moves 7.3% Higher - Tale of the Tape
Merck Sells Japan Eye-Treatment Rights (Fox Business)

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of profit margin.

The trailing-twelve-month profit margin at Hi Tech Pharmacal Co (NASDAQ: HITK) is 15.77%. Hi Tech Pharmacal's ROE for the same period is 15.20%.

The trailing-twelve-month profit margin at Akorn (NASDAQ: AKRX) is 13.81%. Akorn had $40.78 million in total cash for the latest quarter.

The trailing-twelve-month profit margin at Mylan (NASDAQ: MYL) is 9.43%. Mylan's revenue for the same period is $6.80 billion.

The trailing-twelve-month profit margin at Salix Pharmaceuticals (NASDAQ: SLXP) is 8.74%. Salix's ROA for the same period is 7.24%.

Posted-In: Drugs-Generic Industry Highest Profit MarginTrading Ideas

 

Related Articles (AKRX + HITK)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters